Literature DB >> 29232248

Endocarditis in the setting of IDU: multidisciplinary management.

Bobby Yanagawa1, Anees Bahji2, Wiplove Lamba3, Darrell H Tan4, Asim Cheema5, Ishba Syed5, Subodh Verma1.   

Abstract

PURPOSE OF REVIEW: The purpose of this article is to provide a brief overview of the medical and surgical management of infective endocarditis secondary to IDU, with a focus on the underlying substance use disorder. RECENT
FINDINGS: Patients with infective endocarditis secondary to IDU are often young with unique comorbidities including mental illness, chronic hepatitis C, HIV infection, which are often compounded by limited social and familial supports. The focus of management has been treatment of endocarditis using IV antibiotics alongside surgery. Surgical outcomes compare favorably with those of infective endocarditis in the general population but long-term outcomes of IDUs are significantly worse. This is primarily due to the high rate of recidivism of drug use and the risk of prosthetic valve infective endocarditis. Contemporary management of addiction utilizes an integrative approach, combining both pharmacologic and nonpharmacologic strategies while remaining patient-centered. Given the complexity of care required, we advocate for a multidisciplinary team-based approach including psychiatry, infectious disease, cardiology, cardiac surgery and social services.
SUMMARY: Infective endocarditis secondary to IDU remains a medical and surgical challenge with dismal outcomes. Here we offer practical suggestions on the multidisciplinary management of this challenging and high-risk patient cohort.

Entities:  

Mesh:

Year:  2018        PMID: 29232248     DOI: 10.1097/HCO.0000000000000493

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  9 in total

1.  Infectious Complications of Addiction: A Call for a New Subspecialty Within Infectious Diseases.

Authors:  David P Serota; Joshua A Barocas; Sandra A Springer
Journal:  Clin Infect Dis       Date:  2020-02-14       Impact factor: 9.079

2.  Impact of Substance Use Disorder on Midterm Mortality After Valve Surgery for Endocarditis.

Authors:  Alysse G Wurcel; Griffin Boll; Deirdre Burke; Rani Khetarpal; Patrick J Warner; Alice M Tang; Kenneth G Warner
Journal:  Ann Thorac Surg       Date:  2019-10-17       Impact factor: 4.330

3.  The Opioid Crisis and the Inpatient Floor: Considering Injection Drug Use in the Management of Infective Endocarditis and Acute Pain.

Authors:  Lauren M Mitchell; Aimee Milliken; Mary W Montgomery; Steve K Singh; Joji Suzuki
Journal:  Harv Rev Psychiatry       Date:  2020 Sep/Oct       Impact factor: 3.732

4.  Injection Drug Use Endocarditis: An Inner-City Hospital Experience.

Authors:  Ishba M Syed; Bobby Yanagawa; Suganthiny Jeyaganth; Subodh Verma; Asim N Cheema
Journal:  CJC Open       Date:  2021-03-09

Review 5.  Infective endocarditis - can we treat it more effectively?

Authors:  Aneta Guzek; Wojciech Braksator; Zbigniew Gąsior; Mariusz Kuśmierczyk; Jacek Różański; Zbigniew Rybicki
Journal:  Kardiochir Torakochirurgia Pol       Date:  2020-04-08

6.  Long term surgical outcomes for infective endocarditis in people who inject drugs: a systematic review and meta-analysis.

Authors:  David Goodman-Meza; Robert E Weiss; Sebastián Gamboa; Abel Gallegos; Alex A T Bui; Matthew B Goetz; Steven Shoptaw; Raphael J Landovitz
Journal:  BMC Infect Dis       Date:  2019-11-08       Impact factor: 3.090

7.  The Epidemiology of Endocarditis in Manitoba: A Retrospective Study.

Authors:  Duncan J Maguire; Rakesh C Arora; Brett M Hiebert; Brenden Dufault; Mullein D Thorleifson
Journal:  CJC Open       Date:  2021-07-29

8.  Unequal access to opioid agonist treatment and sterile injecting equipment among hospitalized patients with injection drug use-associated infective endocarditis.

Authors:  Thomas D Brothers; Kimiko Mosseler; Susan Kirkland; Patti Melanson; Lisa Barrett; Duncan Webster
Journal:  PLoS One       Date:  2022-01-26       Impact factor: 3.240

9.  A retrospective cohort study evaluating correlates of deep tissue infections among patients enrolled in opioid agonist treatment using administrative data in Ontario, Canada.

Authors:  Kristen A Morin; Chad R Prevost; Joseph K Eibl; Michael T Franklyn; Alexander R Moise; David C Marsh
Journal:  PLoS One       Date:  2020-04-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.